Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib tablets 0 01.07.2024 08:14 Business Standard Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for Bosutinib Tablets, 100 mg and 500 mg. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
